搜尋結果
J&J's drug eases depression and insomnia symptoms in late-stage study
Reuters· 2 日前, opens new tab experimental drug helped reduce symptoms of depression as well as insomnia in ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 bln
Reuters· 2 日前The deal is the latest in a string of recent acquisitions by Merck ...
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
CNBC· 2 日前The supply tracker could be a valuable tool for many Americans scrambling to get their ...
Merck to buy eye-focused drug developer EyeBio for as much as $3 billion
CNBC· 2 日前It agreed to pay $1.3 billion in cash and another $1.7 billion in future milestone-based ...
South African Voters Set to Snub Mandela’s Party - What’s News - WSJ Podcasts
The Wall Street Journal· 2 日前Peter Granitz: Chicago has an idea to save its dying downtown, give developers millions of dollars to attract tenants. Plus ...
Forbes Daily: The Next Philanthropic Chapter For Melinda French Gates
Forbes· 3 日前... estimates is worth $11.1 billion as of Tuesday morning, said she has “long focused on impr ...
Cannabis Rescheduling Vs. Descheduling: The Supply Chain Edition
Forbes· 3 日前By now, most of you know that the Drug Enforcement Administration (DEA) has accepted ... ...
The Democratic Bill To Raise Drug Prices By Protecting Patent Trolls
Forbes· 3 日前In part this is because there are lots of subtle things one can tweak about how a biologic drug ...
Backed By Billionaires, This Biotech Venture Capital Fund Is Driving Innovation In Taiwan
Forbes· 3 日前Global momentum in biotechnology is paying off for the founding partners of Diamond Biofund,
How Physical And Mental Wellness Impacts Entrepreneurs
Forbes· 3 日前Entrepreneurs are human beings who can get sick, face mental health challenges, and spiral into ...